Journal of the advanced practitioner in oncology最新文献

筛选
英文 中文
Responding to the Evolving Treatment Paradigm for Myelofibrosis: Narratives on Collaboration 应对骨髓纤维化治疗模式的演变:关于协作的叙述
Journal of the advanced practitioner in oncology Pub Date : 2019-12-01 DOI: 10.6004/jadpro.2019.10.8.11
Karen Schiavo, ARNP, AOCNP
{"title":"Responding to the Evolving Treatment Paradigm for Myelofibrosis: Narratives on Collaboration","authors":"Karen Schiavo, ARNP, AOCNP","doi":"10.6004/jadpro.2019.10.8.11","DOIUrl":"https://doi.org/10.6004/jadpro.2019.10.8.11","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41459798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Responding to the Evolving Treatment Paradigm for Myelofibrosis: Narratives on Collaboration 响应不断发展的骨髓纤维化治疗范式:合作叙事
Journal of the advanced practitioner in oncology Pub Date : 2019-12-01 DOI: 10.6004/iadpro.2019.10.8.11
Karen Schiavo, Arnp, Aocnp
{"title":"Responding to the Evolving Treatment Paradigm for Myelofibrosis: Narratives on Collaboration","authors":"Karen Schiavo, Arnp, Aocnp","doi":"10.6004/iadpro.2019.10.8.11","DOIUrl":"https://doi.org/10.6004/iadpro.2019.10.8.11","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42064890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Myeloid Leukemia: An Ever-Changing Disease 急性髓性白血病:一种不断变化的疾病
Journal of the advanced practitioner in oncology Pub Date : 2019-11-01 DOI: 10.6004/jadpro.2019.10.8.12
Nancy M. Nix, Allyson Price
{"title":"Acute Myeloid Leukemia: An Ever-Changing Disease","authors":"Nancy M. Nix, Allyson Price","doi":"10.6004/jadpro.2019.10.8.12","DOIUrl":"https://doi.org/10.6004/jadpro.2019.10.8.12","url":null,"abstract":"Abstract Acute myeloid leukemia is the most common form of acute leukemia in adults. In recent years, there has been robust characterization of molecular targets for drug development, leading to the U.S. Food & Drug Administration approval of numerous new treatments during 2017 and 2018. In light of these new approvals, this article provides an update for advanced practitioners on risk stratification, which is critical for guiding treatment selection.","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"10 1","pages":"4 - 8"},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43056867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Narratives on Collaboration: Optimizing Management of Immune-Related Adverse Events 协作叙述:优化免疫相关不良事件的管理
Journal of the advanced practitioner in oncology Pub Date : 2019-07-01 DOI: 10.6004/JADPRO.2019.10.5.9
Marianne J. Davies, DNP, CNS, ACNP, AOCNP, Kristen Crowley, MSN, APRN
{"title":"Narratives on Collaboration: Optimizing Management of Immune-Related Adverse Events","authors":"Marianne J. Davies, DNP, CNS, ACNP, AOCNP, Kristen Crowley, MSN, APRN","doi":"10.6004/JADPRO.2019.10.5.9","DOIUrl":"https://doi.org/10.6004/JADPRO.2019.10.5.9","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45462370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR T-Cell Therapy for Large B-Cell Lymphoma CAR - t细胞治疗大b细胞淋巴瘤
Journal of the advanced practitioner in oncology Pub Date : 2019-05-01 DOI: 10.6004/jadpro.2019.10.4.9
M. Alencar
{"title":"CAR T-Cell Therapy for Large B-Cell Lymphoma","authors":"M. Alencar","doi":"10.6004/jadpro.2019.10.4.9","DOIUrl":"https://doi.org/10.6004/jadpro.2019.10.4.9","url":null,"abstract":"Chimeric antigen receptor (CAR) T-cell therapy represents an exciting innovation in the treatment of cancer. With the approval of two revolutionary anti-CD19 CAR T-cell therapies (axicabtagene ciloleucel [Yescarta] and tisagenlecleucel [Kymriah]) for relapsed/refractory large B-cell lymphoma, health-care providers must consider how to prepare for the future of cancer care. While these therapies have been shown to provide clinical benefit to many patients, they are associated with a range of adverse events (AEs) that will need to be identified, assessed, and managed. Widespread education of health-care providers, patients, and caregivers will also be essential to ensure the success of this novel treatment. This supplement aims to provide practical information to the advanced practitioner on a number of considerations relating to the implementation and expansion of CAR T-cell therapy, including CAR T-cell biology and mechanism of action, how to identify, grade, and manage treatment-related AEs, as well as best practices for educating patients and caregivers about this type of therapy.","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"10 1","pages":"5 - 9"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47327888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in the Treatment of HER2-Positive Breast Cancer her2阳性乳腺癌的治疗进展
Journal of the advanced practitioner in oncology Pub Date : 2019-04-01 DOI: 10.6004/jadpro.2019.10.3.6
{"title":"Advances in the Treatment of HER2-Positive Breast Cancer","authors":"","doi":"10.6004/jadpro.2019.10.3.6","DOIUrl":"https://doi.org/10.6004/jadpro.2019.10.3.6","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43421584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2017-2018 Drug Approvals in Solid Tumors 2017-2018年实体肿瘤药物批准
Journal of the advanced practitioner in oncology Pub Date : 2019-04-01 DOI: 10.6004/JADPRO.2019.10.3.3
P. Kiel, Pharmd, Bcps, Bcop
{"title":"2017-2018 Drug Approvals in Solid Tumors","authors":"P. Kiel, Pharmd, Bcps, Bcop","doi":"10.6004/JADPRO.2019.10.3.3","DOIUrl":"https://doi.org/10.6004/JADPRO.2019.10.3.3","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46394069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Implications for Women With Breast Cancer 癌症患者的手术意义
Journal of the advanced practitioner in oncology Pub Date : 2019-04-01 DOI: 10.6004/jadpro.2019.10.3.7
{"title":"Surgical Implications for Women With Breast Cancer","authors":"","doi":"10.6004/jadpro.2019.10.3.7","DOIUrl":"https://doi.org/10.6004/jadpro.2019.10.3.7","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46408594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sequencing Therapies in Indolent Lymphomas 惰性淋巴瘤的测序治疗
Journal of the advanced practitioner in oncology Pub Date : 2019-04-01 DOI: 10.6004/jadpro.2019.10.3.15
{"title":"Sequencing Therapies in Indolent Lymphomas","authors":"","doi":"10.6004/jadpro.2019.10.3.15","DOIUrl":"https://doi.org/10.6004/jadpro.2019.10.3.15","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45049479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Directions in Acute Myeloid Leukemia 急性髓细胞白血病研究的新方向
Journal of the advanced practitioner in oncology Pub Date : 2019-04-01 DOI: 10.6004/JADPRO.2019.10.3.18
P. Viale
{"title":"New Directions in Acute Myeloid Leukemia","authors":"P. Viale","doi":"10.6004/JADPRO.2019.10.3.18","DOIUrl":"https://doi.org/10.6004/JADPRO.2019.10.3.18","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44591905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信